Exact Sciences Corporation (NASDAQ: EXAS) stock closed at 65.06 per share at the end of the most recent trading day (a 0.14% change compared to the prior day closing price) with a volume of 1.35M shares and market capitalization of 11.77B. Is a component of Russell 1000 indices and it is traded on NASDAQ exchange. The company belongs in the Medical Diagnostics & Research industry, Healthcare sector and employs 5000 people. Exact Sciences Corporation CEO is Kevin T. Conroy.

The one-year performance of Exact Sciences Corporation stock is 57.73%, while year-to-date (YTD) performance is 31.41%. EXAS stock has a five-year performance of -16.57%. Its 52-week range is between 40.73 and 100.77, which gives EXAS stock a 52-week price range ratio of 40.52%

Exact Sciences Corporation currently has a PE ratio of -11.50, a price-to-book (PB) ratio of 2.70, a price-to-sale (PS) ratio of 6.83, a price to cashflow ratio of 364.30, a PEG ratio of -0.22, a ROA of -12.00%, a ROC of -12.34% and a ROE of -23.73%. The company’s profit margin is -32.38%, its EBITDA margin is -26.00%, and its revenue ttm is $1.53 Billion , which makes it $8.62 revenue per share.

Of the last four earnings reports from Exact Sciences Corporation, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $-0.49 for the next earnings report. Exact Sciences Corporation’s next earnings report date is -.

The consensus rating of Wall Street analysts for Exact Sciences Corporation is Strong Buy (1.35), with a target price of $61.09, which is -6.10% compared to the current price. The earnings rating for Exact Sciences Corporation stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Exact Sciences Corporation has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Exact Sciences Corporation has a Neutral technical analysis rating based on Technical Indicators (ADX : 15.93, ATR14 : 2.84, CCI20 : 68.38, Chaikin Money Flow : -0.10, MACD : 0.03, Money Flow Index : 39.74, ROC : 9.09, RSI : 50.97, STOCH (14,3) : 61.22, STOCH RSI : 0.04, UO : 38.32, Williams %R : -38.78), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Exact Sciences Corporation in the last 12-months were: Brian Baranick (Sold 0 shares of value $0 ), Brian Baranick (Sold 2 770 shares of value $170 643 ), Condella Sarah (Option Excercise at a value of $0), Condella Sarah (Sold 21 574 shares of value $1 562 325 ), Conroy Kevin (Option Excercise at a value of $0), Conroy Kevin (Sold 34 324 shares of value $2 186 371 ), Coward D. (Option Excercise at a value of $0), Coward D. (Sold 6 981 shares of value $436 430 ), Cunningham Everett (Sold 0 shares of value $0 ), Cunningham Everett (Sold 16 635 shares of value $1 089 808 ), Doyle James (Option Excercise at a value of $90 480), Doyle James (Sold 3 402 shares of value $288 135 ), Doyle James Edward (Sold 2 000 shares of value $194 840 ), Elliott Jeffrey (Option Excercise at a value of $0), Elliott Jeffrey (Sold 8 687 shares of value $545 550 ), Everett V. Cunningham (Option Excercise at a value of $0), Everett V. Cunningham (Sold 3 628 shares of value $224 972 ), Herriott James (Sold 1 300 shares of value $130 000 ), James E. Doyle (Option Excercise at a value of $90 480), James Herriott (Option Excercise at a value of $0), James Herriott (Sold 3 023 shares of value $185 652 ), Jeffrey T. Elliott (Option Excercise at a value of $0), Jeffrey T. Elliott (Sold 8 687 shares of value $545 550 ), Kevin T. Conroy (Option Excercise at a value of $0), Kevin T. Conroy (Sold 34 324 shares of value $2 186 371 ), Napier Katherine (Sold 3 027 shares of value $273 974 ), Orville Jacob (Option Excercise at a value of $0), Orville Jacob (Sold 20 496 shares of value $1 373 232 ), Sarah Condella (Option Excercise at a value of $0), Sarah Condella (Sold 8 987 shares of value $564 035 ), Scott D. Coward (Option Excercise at a value of $0), Scott D. Coward (Sold 6 981 shares of value $436 430 )